In 2023, Germany led global government expenditure in R&D for medical and health sciences with significant growth at 8.06% YoY, followed by Japan. Spain and Russia also demonstrated moderate increases. Conversely, the United Kingdom and the Netherlands experienced substantial decreases. Despite positive YoY changes in most countries, some, like Finland, faced declines. On a five-year scale, countries such as Iceland showed impressive annual growth rates. These variations indicate diverse national priorities and economic conditions influencing R&D investment choices.
Future trends to watch include increased investment in emerging technologies and personalized medicine, influenced by aging populations and global health challenges. Economic conditions and political stability will continue to play critical roles in shaping government spending strategies in the medical and health sciences sector.
Top countries in Government Expenditure on R&D in Medical and Health Sciences by Country
| # | 10 Countries | Million US Dollars PPP = 2015 | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 2,620 | 2023 | +6.79% | +8.06% | View data |
| 2 | 2 Japan | 1,990 | 2023 | +5.65% | +6.57% | View data |
| 3 | 3 Spain | 1,490 | 2023 | +4.5% | +4.01% | View data |
| 4 | 4 Russia | 1,200 | 2023 | +2.04% | +1.53% | View data |
| 5 | 5 Italy | 1,060 | 2023 | +1.28% | +2.93% | View data |
| 6 | 6 Taiwan | 1,020 | 2023 | +0.87% | +0.54% | View data |
| 7 | 7 Singapore | 471.63 | 2023 | +3.31% | +5.71% | View data |
| 8 | 8 South Korea | 434.51 | 2023 | +8.82% | +3.84% | View data |
| 9 | 9 Norway | 183.51 | 2023 | +2.43% | +1.76% | View data |
| 10 | 10 Portugal | 101.6 | 2023 | +1.74% | +3.83% | View data |
